Among ER+HER2− subtypes, survival was markedly poorer for grade III compared to grade II tumours (Fig. 1a, b), and the mortality rate remained elevated up to 13 years after diagnosis (Fig. 1g, h). Here, ESR1 is linked to neoplasm.